Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Physicians criticize remdesivir distribution process
Beckers Hospital Review
Thu, 05/7/20 - 10:53 am
Tags:
physicians, Gilead Sciences, COVID-19, remdesivir
From Gilead To AstraZeneca, Investors Should Watch These Biotech Giants Right Now
Motley Fool
Thu, 05/7/20 - 10:46 am
Tags:
FDA, drug approvals, Gilead Sciences, remdesivir, AstraZeneca, Merck, Lynparza, Clovis Oncology, Rubraca, Bristol-Myers Squibb, Opdivo, Yervoy
After donation to the U.S., Gilead outlines plans to distribute COVID-19 drug worldwide
BioPharma Dive
Thu, 05/7/20 - 12:24 am
Tags:
Gilead Sciences, pandemic, remdesivir, COVID-19
Here’s how some big U.S. drugmakers expect Covid-19 to affect them this year
MedCity News
Mon, 05/4/20 - 10:37 pm
Tags:
COVID-19, pandemic, Gilead Sciences, Pfizer, Eli Lilly, JNJ, Merck, Amgen
Here’s What Politicians Often Get Wrong About Remdesivir, Gilead’s Coronavirus Treatment
Forbes
Mon, 05/4/20 - 10:32 pm
Tags:
Gilead Sciences, remdesivir, politicians
First doses of Gilead’s COVID-19 drug remdesivir to arrive at US hospitals
Pharmaforum
Mon, 05/4/20 - 10:30 am
Tags:
Gilead Sciences, remdesivir, pandemic, COVID-19
Entire Stockpile Of Coronavirus Treatment Remdesivir Donated To Government, Says CEO
Forbes
Sun, 05/3/20 - 08:10 pm
Tags:
Gilead Sciences, remdesivir, Daniel O'Day, pandemic, COVID-19, federal government
FDA Authorizes Gilead's Remdesivir for COVID-19
Motley Fool
Sat, 05/2/20 - 11:35 pm
Tags:
Gilead Sciences, FDA, COVID-19, remdesivir, Emergency Use Authorization
How Gilead's coronavirus drug breakthrough is setting the tone for other potential treatments
Yahoo Finance
Sat, 05/2/20 - 11:19 pm
Tags:
Gilead Sciences, remdesivir, COVID-19, pandemic
3 Big Stories in Gilead Sciences' Q1 Results
Motley Fool
Fri, 05/1/20 - 11:04 am
Tags:
earnings, Gilead Sciences, remdesivir, COVID-19
Doctors anticipate patient requests for experimental remdesivir before all the evidence comes in
Stat
Thu, 04/30/20 - 10:46 pm
Tags:
physicians, Gilead Sciences, remdesivir, COVID-19
After NIH trial, EMA begins rolling review for remdesivir, setting up potential authorizations in US and Europe
Endpoints
Thu, 04/30/20 - 10:43 pm
Tags:
Gilead Sciences, remdesivir, COVID-19, EMA, NIH, FDA, Europe
Gilead’s Antiviral Remdesivir Had A Good Day - But It’s Still Not Clear How Effective It Is Against COVID-19
Forbes
Wed, 04/29/20 - 10:58 pm
Tags:
Gilead Sciences, remdesivir, clinical trials, COVID-19, antivirals
Gilead CEO: We’re going to make sure that access is not an issue with remdesivir
Stat
Wed, 04/29/20 - 10:54 pm
Tags:
Gilead Sciences, Daniel O'Day, Pharma CEOs, remdesivir, COVID-19, pandemic, access
Gilead says critical study of Covid-19 drug shows patients are responding to treatment
Stat
Wed, 04/29/20 - 10:58 am
Tags:
Gilead Sciences, remdesivir, clinical trials, COVID-19
The world wants answers on Gilead’s Covid-19 drug. Experts worry next studies may increase uncertainty
Stat
Tue, 04/28/20 - 11:02 am
Tags:
Gilead Sciences, remdesivir, COVID-19, pandemic
Gilead's COVID-19 hopeful remdesivir may get swift Japanese approval: report
Fierce Biotech
Mon, 04/27/20 - 09:40 am
Tags:
Japan, Gilead Sciences, remdesivir, COVID-19
Here's What to Expect With Gilead Sciences' Q1 Earnings Update
Motley Fool
Mon, 04/27/20 - 09:23 am
Tags:
Gilead Sciences, earnings
AbbVie, Lilly and Gilead stay on top of pharma ad spending list for March amid steady overall spending
Fierce Pharma
Mon, 04/27/20 - 09:21 am
Tags:
AbbVie, Eli Lilly, Gilead Sciences, pharma advertising, DTC ads, television ads, pandemic, COVID-19
Gilead charges CDC with contract breach on HIV research
Seeking Alpha
Sun, 04/26/20 - 08:31 pm
Tags:
Gilead Sciences, CDC, patents, lawsuits, HIV, R&D

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.